CDK2 and non-small cell lung carcinoma: demonstrated that YTHDF1 is amplified and increases the translation of key regulators of the G0/G1 cell cycle transition, including CDK2, CDK4, and cyclin D1 mRNAs, intensifying non-small cell lung cancer (NSCLC) progression under normoxia conditions (227).